4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
9.66
+0.24 (2.55%)
At close: Jun 18, 2026, 4:00 PM EDT
9.91
+0.25 (2.62%)
After-hours: Jun 18, 2026, 6:42 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $504.99 million as of June 18, 2026. Its market cap has increased by 184.62% in one year.
Market Cap
504.99M
Enterprise Value
67.89M
1-Year Change
184.62%
Ranking
Category
Stock Price
$9.66
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $504.99M, a decrease of -12.99%. That is a compound annual growth rate of -2.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 504.99M | 17.85% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 513.41M |
| Valneva SE | 511.98M |
| Indaptus Therapeutics | 509.59M |
| Rezolute | 500.40M |
| AgomAb Therapeutics NV | 497.40M |
| Arvinas | 494.88M |
| Kyverna Therapeutics | 486.66M |
| Neurogene | 486.54M |